Congestive heart failure and Alzheimer's disease

M Cristina Polidori1, Elena Mariani, Patrizia Mecocci

  • 1Unit of Cognitive Frailty, Neurology Outpatient Clinic Dr. Nelles, Cologne, Germany. polidori@uni-duesseldorf.de

Neurological Research
|September 2, 2006
PubMed

Insights

Congestive heart failure (CHF) is linked to cognitive impairment, increasing dementia risk in elderly patients. Early detection and management, including medication and lifestyle changes, are crucial for preventing further decline.

Area of Science:

  • Gerontology
  • Cardiology
  • Neurology

Background:

  • Rising life expectancy leads to increased prevalence of chronic illnesses like cardiovascular disease and dementia.
  • Congestive heart failure (CHF) is an advanced cardiac disease frequently associated with cognitive impairment.
  • The aging population will exacerbate the impact of mild cognitive impairment (MCI), Alzheimer's disease (AD), and CHF.

Purpose of the Study:

  • To review the relationship between CHF and cognitive impairment.
  • To explore the pathophysiology of cardiac failure in cognitive impairment and potential preventive strategies for AD.
  • To emphasize the importance of early detection and management of cognitive issues in CHF patients.

Main Methods:

  • Literature review focusing on CHF and cognitive impairment, particularly in the context of AD.
  • Discussion of pathophysiological mechanisms linking cardiac function and cognitive decline.
  • Evaluation of diagnostic and therapeutic strategies for cognitive impairment in CHF.

Main Results:

  • CHF is a significant factor in cognitive impairment, with potential links to AD development.
  • Preventive strategies include managing oxidative stress, using nitric oxide donors, and ensuring adequate antioxidant supply.
  • Neuropsychological testing is vital for identifying early cognitive deficits and associated conditions like depression.

Conclusions:

  • Systematic neuropsychological assessment in CHF patients is essential for early detection of cognitive impairment.
  • Timely intervention with standard therapies (ACE inhibitors, digoxin, beta-blockers) and lifestyle modifications can mitigate cognitive decline.
  • Comprehensive management plans incorporating exercise, patient education, and caregiver support are recommended.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...